This document is a publication of a patent application (US20260083686A1) filed with the USPTO on November 24, 2025. The application, by inventors Alexander Zaika and Sergey I Dikalov, describes compounds and methods aimed at suppressing or ameliorating the accumulation of reflux-induced protein adducts. The CPC classifications indicate relevance to pharmaceutical preparations (A61K) and therapeutic uses for diseases of the digestive system (A61P 1/04).

As this is a patent application, it does not impose immediate compliance obligations on regulated entities. However, it signals potential future developments in therapeutic approaches for conditions related to acid reflux. Companies in the pharmaceutical and drug development sectors should monitor the progress of this application and related intellectual property, as granted patents could impact market exclusivity and future product development strategies in this therapeutic area.